Plain-English translation of NCT06878417 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether oral cannabis extracts—specifically cannabidiol () and tetrahydrocannabinol ()—can help reduce arthritis pain in people with osteoarthritis of the knee or hip. Many people are already using cannabis for arthritis pain, but there isn't strong scientific evidence showing whether it actually works. This study will help answer that question by comparing the medication to a placebo (a dummy pill) over 8 weeks.
Osteoarthritis causes significant pain and disability for many people, and current pain treatments don't work well enough for everyone or can cause side effects. Because so many patients are turning to this medication on their own without clear medical guidance, researchers need high-quality evidence to understand if it truly helps and what dose works best.
You likely qualify if…
You likely don't qualify if…
You will take a capsule once daily for 8 weeks—either the active medication, a different dose, or a placebo (dummy pill). You won't know which one you're taking, and neither will the researchers at first, to keep results fair. You'll likely have a few visits to the research team to answer questions about your pain levels and how you're doing, and you'll need to commit to staying in the same location for the 4 months of the study.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
Canada